Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate

Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate

Abstract Chronic myelomonocytic leukemia (CMML) is an entity of myelodysplastic syndrome/myeloproliferative neoplasm. Although CMML can be cured with allogeneic stem cell transplantation, its prognosis is generally very poor due to the limited efficacy of chemotherapy and to the patient’s age, which...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kazuki Taoka, Shunya Arai, Keisuke Kataoka, Masataka Hosoi, Masashi Miyauchi, Sho Yamazaki, Akira Honda, Wei Aixinjueluo, Takashi Kobayashi, Keiki Kumano, Akihide Yoshimi, Makoto Otsu, Akira Niwa, Tatsutoshi Nakahata, Hiromitsu Nakauchi, Mineo Kurokawa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Chronic Myelomonocytic Leukemia (CMML)
Clodronate Liposomes
Drug Testing Systems
Teratoma
Hematopoietic Progenitor Cells (HPCs)
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/ca6c14c5e42546afa52dabe821a5a19d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/ca6c14c5e42546afa52dabe821a5a19d

Ejemplares similares